Artivion Inc (AORT)

May 28, 2025, 5:51 PM EDT - 2 days ago

Artivion Announces Closing of Transactions to Exchange $99.5 Million in Principal Amount of its 4.250% Convertible Notes Due 2025 for Common Stock

May 14, 2025, 4:01 PM EDT - 16 days ago

Artivion Announces Agreements to Exchange $95 Million in Principal Amount of its 4.250% Convertible Notes Due 2025 for Common Stock

May 5, 2025, 10:37 PM EDT - 25 days ago

Artivion, Inc. (AORT) Q1 2025 Earnings Call Transcript

May 5, 2025, 4:05 PM EDT - 25 days ago

Artivion Reports First Quarter 2025 Financial Results

May 5, 2025, 7:00 AM EDT - 25 days ago

Artivion Announces Presentation of New Clinical Data from NEXUS TRIOMPHE IDE Trial at the 105th American Association for Thoracic Surgery (AATS) Annual Meeting

Apr 21, 2025, 4:10 PM EDT - 5 weeks ago

Artivion Announces Release Date and Teleconference Call Details for First Quarter 2025 Financial Results

Mar 4, 2025, 4:05 PM EST - 3 months ago

Artivion to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

Feb 24, 2025, 11:00 PM EST - 3 months ago

Artivion, Inc. (AORT) Q4 2024 Earnings Call Transcript

Feb 24, 2025, 4:05 PM EST - 3 months ago

Artivion Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 10, 2025, 4:10 PM EST - 3 months ago

Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2024 Financial Results

Jan 27, 2025, 8:00 AM EST - 4 months ago

Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 61st Society of Thoracic Surgery Annual Meeting

Dec 9, 2024, 10:52 AM EST - 6 months ago

US medical device giant Artivion says hackers stole files during cybersecurity incident

Dec 9, 2024, 8:00 AM EST - 6 months ago

Artivion Granted FDA Humanitarian Device Exemption for the AMDS Hybrid Prosthesis

Nov 9, 2024, 12:02 PM EST - 7 months ago

Artivion, Inc. (AORT) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 4:05 PM EST - 7 months ago

Artivion Reports Third Quarter 2024 Financial Results

Nov 5, 2024, 4:15 PM EST - 7 months ago

Artivion to Participate in Upcoming Investor Conferences

Oct 24, 2024, 4:15 PM EDT - 7 months ago

Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2024 Financial Results

Oct 10, 2024, 4:10 PM EDT - 8 months ago

Artivion Announces Presentation of Late-Breaking Clinical Data at the 38th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting

Aug 10, 2024, 2:45 PM EDT - 10 months ago

Artivion, Inc. (AORT) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 4:05 PM EDT - 10 months ago

Artivion Reports Second Quarter 2024 Financial Results

Jul 25, 2024, 4:10 PM EDT - 11 months ago

Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2024 Financial Results

Jul 1, 2024, 4:05 PM EDT - 11 months ago

Artivion Amends Agreements with Endospan

Jun 21, 2024, 5:01 PM EDT - 1 year ago

Data-Driven Growth Fuels More Upside For Overlooked Artivion

May 6, 2024, 10:47 PM EDT - 1 year ago

Artivion, Inc. (AORT) Q1 2024 Earnings Call Transcript

May 6, 2024, 4:05 PM EDT - 1 year ago

Artivion Reports First Quarter 2024 Financial Results

Apr 29, 2024, 8:05 AM EDT - 1 year ago

Artivion Announces Presentation of New Clinical Data for On-X Aortic Heart Valve and AMDS at the 104th American Association for Thoracic Surgery (AATS) Annual Meeting

Apr 22, 2024, 4:10 PM EDT - 1 year ago

Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial Results

Apr 1, 2024, 4:10 PM EDT - 1 year ago

Artivion to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Mar 6, 2024, 4:10 PM EST - 1 year ago

Artivion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Feb 15, 2024, 8:22 PM EST - 1 year ago

Artivion, Inc. (AORT) Q4 2023 Earnings Call Transcript

Feb 15, 2024, 4:05 PM EST - 1 year ago

Artivion Reports Fourth Quarter and Full Year 2023 Financial Results

Feb 1, 2024, 4:10 PM EST - 1 year ago

Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2023 Financial Results

Jan 29, 2024, 8:25 AM EST - 1 year ago

Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 60th Society of Thoracic Surgery Annual Meeting

Jan 18, 2024, 4:05 PM EST - 1 year ago

Artivion Obtains $350 Million in Senior Secured Credit Facilities

ARES

Dec 6, 2023, 4:15 PM EST - 1 year ago

Artivion Appoints Lance A. Berry as Executive Vice President, Chief Financial Officer; Announces Retirement of D.

Nov 9, 2023, 8:25 AM EST - 1 year ago

Artivion Announces Completion of Enrollment in PERSEVERE Trial

Nov 5, 2023, 1:51 AM EDT - 1 year ago

Artivion, Inc. (AORT) Q3 2023 Earnings Call Transcript

Nov 2, 2023, 4:05 PM EDT - 1 year ago

Artivion Reports Third Quarter 2023 Financial Results

Oct 19, 2023, 4:10 PM EDT - 1 year ago

Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2023 Financial Results

Oct 13, 2023, 2:37 PM EDT - 1 year ago

Artivion's Ongoing Clinical Studies Could Drive Significant Growth Starting In 2025

Oct 5, 2023, 4:15 PM EDT - 1 year ago

Artivion Announces Presentation of Real World Data from Post Market Study of On-X® Aortic Heart Valve Replacement Patients Treated with Low Dose Warfarin

Oct 5, 2023, 4:05 PM EDT - 1 year ago

Artivion Announces Presentation of Late-Breaking Interim Data from AMDS PERSEVERE Trial at the 37th European Association for Cardio-Thoracic Surgery Annual Meeting

Sep 26, 2023, 8:25 AM EDT - 1 year ago

Artivion to Present at the Deutsche Bank 31st Annual Leveraged Finance Conference

Sep 14, 2023, 8:05 AM EDT - 1 year ago

Artivion to Present at the Gilmartin Group Emerging Growth Company Showcase

Aug 5, 2023, 1:28 PM EDT - 1 year ago

Artivion, Inc. (AORT) Q2 2023 Earnings Call Transcript

Aug 3, 2023, 4:05 PM EDT - 1 year ago

Artivion Reports Second Quarter 2023 Financial Results

Jul 20, 2023, 8:25 AM EDT - 2 years ago

Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2023 Financial Results

Jul 19, 2023, 10:16 PM EDT - 2 years ago

Artivion: On-X Sales Double 5-Year Average, Far More Constructive View (Rating Upgrade)

May 23, 2023, 8:04 AM EDT - 2 years ago

Artivion Announces FDA PMA Approval of PerClot and Transfer of PMA to Baxter

BAX

May 7, 2023, 11:49 AM EDT - 2 years ago

Artivion, Inc. (AORT) Q1 2023 Earnings Call Transcript